| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | retinoic acid binding | 2.60e-08 | 28 | 133 | 6 | GO:0001972 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 1.08e-07 | 35 | 133 | 6 | GO:0015020 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 1.53e-07 | 37 | 133 | 6 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 1.81e-07 | 38 | 133 | 6 | GO:0070001 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | DDX49 DNAH10 ATP8A2 DCP2 COQ8B BTAF1 RFC1 RAB40A NLRP3 ARF1 ARF3 ARF4 ABCB1 ARF5 ARF6 RABL2B RABL2A RAB40AL ABCD2 DDX41 | 7.25e-07 | 839 | 133 | 20 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | DDX49 DNAH10 ATP8A2 DCP2 COQ8B BTAF1 RFC1 RAB40A NLRP3 ARF1 ARF3 ARF4 ABCB1 ARF5 ARF6 RABL2B RABL2A RAB40AL ABCD2 DDX41 | 7.39e-07 | 840 | 133 | 20 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | DDX49 DNAH10 ATP8A2 DCP2 COQ8B BTAF1 RFC1 RAB40A NLRP3 ARF1 ARF3 ARF4 ABCB1 ARF5 ARF6 RABL2B RABL2A RAB40AL ABCD2 DDX41 | 7.39e-07 | 840 | 133 | 20 | GO:0016818 |
| GeneOntologyMolecularFunction | retinoid binding | 7.60e-07 | 48 | 133 | 6 | GO:0005501 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 8.62e-07 | 49 | 133 | 6 | GO:0019840 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | DDX49 DNAH10 ATP8A2 COQ8B BTAF1 RFC1 RAB40A NLRP3 ARF1 ARF3 ARF4 ABCB1 ARF5 ARF6 RABL2B RABL2A RAB40AL ABCD2 DDX41 | 9.34e-07 | 775 | 133 | 19 | GO:0017111 |
| GeneOntologyMolecularFunction | poly(A) binding | 3.93e-05 | 29 | 133 | 4 | GO:0008143 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 4.58e-05 | 11 | 133 | 3 | GO:0004523 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 7.51e-05 | 153 | 133 | 7 | GO:0008194 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 8.13e-05 | 107 | 133 | 6 | GO:0033293 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 9.97e-05 | 14 | 133 | 3 | GO:0003964 | |
| GeneOntologyMolecularFunction | poly-purine tract binding | 1.05e-04 | 37 | 133 | 4 | GO:0070717 | |
| GeneOntologyMolecularFunction | phospholipase D activator activity | 1.32e-04 | 3 | 133 | 2 | GO:1990583 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | 2.03e-04 | 239 | 133 | 8 | GO:0031406 | |
| GeneOntologyMolecularFunction | organic acid binding | 3.06e-04 | 254 | 133 | 8 | GO:0043177 | |
| GeneOntologyMolecularFunction | lipid binding | PCYT1A ARHGAP32 UGT1A6 ANXA4 UGT1A5 ICA1 COQ8B DAB1 PICALM NLRP3 SNX13 FABP5 UGT1A4 UGT1A1 UGT1A3 MYOF SNAP91 | 3.07e-04 | 988 | 133 | 17 | GO:0008289 |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 3.52e-04 | 21 | 133 | 3 | GO:0035613 | |
| GeneOntologyMolecularFunction | GTPase activity | 4.73e-04 | 341 | 133 | 9 | GO:0003924 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 5.38e-04 | 211 | 133 | 7 | GO:0016758 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 7.03e-04 | 288 | 133 | 8 | GO:0016757 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DDX49 DNAH10 ATP8A2 COQ8B BTAF1 RFC1 NLRP3 ABCB1 ABCD2 DDX41 | 7.51e-04 | 441 | 133 | 10 | GO:0016887 |
| GeneOntologyMolecularFunction | phosphatidylethanolamine flippase activity | 9.05e-04 | 7 | 133 | 2 | GO:0090555 | |
| GeneOntologyMolecularFunction | GTP binding | 1.38e-03 | 397 | 133 | 9 | GO:0005525 | |
| GeneOntologyMolecularFunction | poly(U) RNA binding | 1.49e-03 | 34 | 133 | 3 | GO:0008266 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 1.90e-03 | 37 | 133 | 3 | GO:0016891 | |
| GeneOntologyMolecularFunction | calcium:sodium antiporter activity | 1.91e-03 | 10 | 133 | 2 | GO:0005432 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 2.06e-03 | 38 | 133 | 3 | GO:0034061 | |
| GeneOntologyMolecularFunction | poly-pyrimidine tract binding | 2.22e-03 | 39 | 133 | 3 | GO:0008187 | |
| GeneOntologyMolecularFunction | large ribosomal subunit rRNA binding | 2.33e-03 | 11 | 133 | 2 | GO:0070180 | |
| GeneOntologyMolecularFunction | endopeptidase activity | ERVK-6 RHBDF1 CAPN3 ERVK-7 ERVK-9 CAPN11 ERVK-8 ERVK-19 ERVK-24 | 2.38e-03 | 430 | 133 | 9 | GO:0004175 |
| GeneOntologyMolecularFunction | guanyl ribonucleotide binding | 2.73e-03 | 439 | 133 | 9 | GO:0032561 | |
| GeneOntologyMolecularFunction | guanyl nucleotide binding | 2.73e-03 | 439 | 133 | 9 | GO:0019001 | |
| GeneOntologyMolecularFunction | clathrin heavy chain binding | 2.78e-03 | 12 | 133 | 2 | GO:0032050 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase binding | 2.93e-03 | 43 | 133 | 3 | GO:0043548 | |
| GeneOntologyMolecularFunction | calcium:monoatomic cation antiporter activity | 3.27e-03 | 13 | 133 | 2 | GO:0015368 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 3.56e-03 | 46 | 133 | 3 | GO:0016893 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase regulatory subunit binding | 3.80e-03 | 14 | 133 | 2 | GO:0036312 | |
| GeneOntologyMolecularFunction | glycerophospholipid flippase activity | 3.80e-03 | 14 | 133 | 2 | GO:0140333 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | ERVK-6 METTL3 DDX49 DCP2 BTAF1 ERVK-7 RFC1 AARSD1 ERVK-8 DDX41 NIPBL | 3.94e-03 | 645 | 133 | 11 | GO:0140640 |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 2.93e-09 | 21 | 131 | 6 | GO:0052695 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 1.21e-08 | 26 | 131 | 6 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 1.21e-08 | 26 | 131 | 6 | GO:0006063 | |
| GeneOntologyBiologicalProcess | neuron development | TANC2 ARHGAP32 GAK ATP8A2 DAB1 PCARE SLC1A3 PICALM PREX2 BDNF NCS1 ARF1 ARF4 ARF6 RABL2B RABL2A EFNB2 SNAP91 ABI2 LMX1B VPS13A ROBO2 CTNNA2 TBC1D23 | 1.52e-05 | 1463 | 131 | 24 | GO:0048666 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | TANC2 ARHGAP32 GAK ATP8A2 CARMIL1 DAB1 ODF2 PICALM BDNF NCS1 ARF4 ARF6 EFNB2 SNAP91 ABI2 ROBO2 CTNNA2 | 2.62e-05 | 846 | 131 | 17 | GO:0120035 |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | TANC2 ARHGAP32 GAK ATP8A2 CARMIL1 DAB1 ODF2 PICALM BDNF NCS1 ARF4 ARF6 EFNB2 SNAP91 ABI2 ROBO2 CTNNA2 | 3.36e-05 | 863 | 131 | 17 | GO:0031344 |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | TANC2 ARHGAP32 GAK ATP8A2 DAB1 PICALM BDNF NCS1 ARF6 EFNB2 SNAP91 ABI2 ROBO2 CTNNA2 | 3.56e-05 | 612 | 131 | 14 | GO:0010975 |
| GeneOntologyBiologicalProcess | bilirubin conjugation | 4.00e-05 | 2 | 131 | 2 | GO:0006789 | |
| GeneOntologyBiologicalProcess | regulation of Arp2/3 complex-mediated actin nucleation | 4.28e-05 | 31 | 131 | 4 | GO:0034315 | |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 5.28e-05 | 12 | 131 | 3 | GO:0052697 | |
| GeneOntologyBiologicalProcess | dendrite development | 5.67e-05 | 335 | 131 | 10 | GO:0016358 | |
| GeneOntologyBiologicalProcess | DNA integration | 6.84e-05 | 13 | 131 | 3 | GO:0015074 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | TANC2 ARHGAP32 ATP8A2 DAB1 SLC1A3 PICALM PREX2 BDNF RABL2B RABL2A EFNB2 SNAP91 ABI2 ROBO2 CTNNA2 | 8.26e-05 | 748 | 131 | 15 | GO:0048667 |
| GeneOntologyBiologicalProcess | synaptic vesicle budding | 1.08e-04 | 15 | 131 | 3 | GO:0070142 | |
| GeneOntologyBiologicalProcess | retrograde trans-synaptic signaling | 1.08e-04 | 15 | 131 | 3 | GO:0098917 | |
| GeneOntologyBiologicalProcess | synapse organization | TANC2 DAB1 PICALM BDNF ARF1 ARF4 ARF6 SLC8A3 EFNB2 SNAP91 ABI2 LMX1B ROBO2 CTNNA2 | 1.18e-04 | 685 | 131 | 14 | GO:0050808 |
| GeneOntologyBiologicalProcess | regulation of actin nucleation | 1.31e-04 | 41 | 131 | 4 | GO:0051125 | |
| GeneOntologyBiologicalProcess | regulation of synapse organization | 1.85e-04 | 387 | 131 | 10 | GO:0050807 | |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 1.87e-04 | 83 | 131 | 5 | GO:0006278 | |
| GeneOntologyBiologicalProcess | cell-cell fusion | 2.09e-04 | 85 | 131 | 5 | GO:0140253 | |
| GeneOntologyBiologicalProcess | syncytium formation by plasma membrane fusion | 2.09e-04 | 85 | 131 | 5 | GO:0000768 | |
| GeneOntologyBiologicalProcess | regulation of synapse structure or activity | 2.18e-04 | 395 | 131 | 10 | GO:0050803 | |
| GeneOntologyBiologicalProcess | Arp2/3 complex-mediated actin nucleation | 2.24e-04 | 47 | 131 | 4 | GO:0034314 | |
| GeneOntologyBiologicalProcess | regulation of terminal button organization | 2.38e-04 | 4 | 131 | 2 | GO:2000331 | |
| GeneOntologyBiologicalProcess | syncytium formation | 2.59e-04 | 89 | 131 | 5 | GO:0006949 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 2.85e-04 | 141 | 131 | 6 | GO:0006805 | |
| GeneOntologyBiologicalProcess | synaptic vesicle transport | 3.84e-04 | 54 | 131 | 4 | GO:0048489 | |
| GeneOntologyBiologicalProcess | flavonoid glucuronidation | 3.95e-04 | 5 | 131 | 2 | GO:0052696 | |
| GeneOntologyBiologicalProcess | clathrin coat assembly | 4.04e-04 | 23 | 131 | 3 | GO:0048268 | |
| GeneOntologyBiologicalProcess | intracellular transport | TANC2 ERVK-6 GAK DNAJC13 AP3B1 REEP2 PICALM ARF1 SNX13 ARF3 ARF4 ARF5 ARF6 SPTBN5 RABL2B RABL2A LMX1B VPS13A TBC1D23 ABCD2 KLC3 | 4.78e-04 | 1496 | 131 | 21 | GO:0046907 |
| GeneOntologyBiologicalProcess | neuron projection development | TANC2 ARHGAP32 GAK ATP8A2 DAB1 PICALM PREX2 BDNF NCS1 ARF1 ARF4 ARF6 EFNB2 SNAP91 ABI2 VPS13A ROBO2 CTNNA2 TBC1D23 | 4.88e-04 | 1285 | 131 | 19 | GO:0031175 |
| GeneOntologyBiologicalProcess | intracellular monoatomic cation homeostasis | SLC24A5 CALB2 TRPC3 CAPN3 AP3B1 SLC1A3 PICALM NCS1 ARF1 BSND SLC8A3 NOS1 | 5.27e-04 | 611 | 131 | 12 | GO:0030003 |
| GeneOntologyBiologicalProcess | cell morphogenesis | TANC2 ARHGAP32 METTL3 ATP8A2 DAB1 AP3B1 SLC1A3 PICALM PREX2 BDNF RABL2B RABL2A EFNB2 SNAP91 ABI2 VPS13A ROBO2 CTNNA2 | 5.54e-04 | 1194 | 131 | 18 | GO:0000902 |
| GeneOntologyBiologicalProcess | inorganic ion homeostasis | SLC24A5 CALB2 TRPC3 CAPN3 AP3B1 SLC1A3 PICALM NCS1 ARF1 BSND SLC8A3 NOS1 | 6.17e-04 | 622 | 131 | 12 | GO:0098771 |
| GeneOntologyBiologicalProcess | intracellular monoatomic ion homeostasis | SLC24A5 CALB2 TRPC3 CAPN3 AP3B1 SLC1A3 PICALM NCS1 ARF1 BSND SLC8A3 NOS1 | 6.17e-04 | 622 | 131 | 12 | GO:0006873 |
| GeneOntologyCellularComponent | postsynaptic density | TANC2 ARHGAP32 RPLP0 PICALM NCS1 ARF1 FABP5 SLC8A3 EFNB2 SNAP91 ROBO2 CTNNA2 NOS1 EPB41L1 | 1.14e-06 | 451 | 133 | 14 | GO:0014069 |
| GeneOntologyCellularComponent | neuron to neuron synapse | TANC2 ARHGAP32 RPLP0 PICALM BDNF NCS1 ARF1 FABP5 SLC8A3 EFNB2 SNAP91 ROBO2 CTNNA2 NOS1 EPB41L1 | 1.25e-06 | 523 | 133 | 15 | GO:0098984 |
| GeneOntologyCellularComponent | asymmetric synapse | TANC2 ARHGAP32 RPLP0 PICALM NCS1 ARF1 FABP5 SLC8A3 EFNB2 SNAP91 ROBO2 CTNNA2 NOS1 EPB41L1 | 2.21e-06 | 477 | 133 | 14 | GO:0032279 |
| GeneOntologyCellularComponent | postsynaptic specialization | TANC2 ARHGAP32 RPLP0 PICALM NCS1 ARF1 FABP5 SLC8A3 EFNB2 SNAP91 ROBO2 CTNNA2 NOS1 EPB41L1 | 4.07e-06 | 503 | 133 | 14 | GO:0099572 |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | GAK ANXA4 ICA1 DAB1 RAB40A SLC1A3 PICALM BDNF NCS1 ARF3 ARF5 UGT1A1 SLC8A3 ANKRD13C RAB40AL BUB1B NOS1 NLRC3 | 2.67e-05 | 934 | 133 | 18 | GO:0048471 |
| GeneOntologyCellularComponent | sperm midpiece | 5.46e-05 | 64 | 133 | 5 | GO:0097225 | |
| GeneOntologyCellularComponent | postsynapse | TANC2 ARHGAP32 RPLP0 SLC1A3 PICALM NCS1 ARF1 ARF4 FABP5 ARF6 SLC8A3 EFNB2 SNAP91 ABI2 ROBO2 CTNNA2 NOS1 EPB41L1 | 8.12e-05 | 1018 | 133 | 18 | GO:0098794 |
| GeneOntologyCellularComponent | parallel fiber to Purkinje cell synapse | 1.59e-04 | 43 | 133 | 4 | GO:0098688 | |
| GeneOntologyCellularComponent | presynapse | GAK CALB2 ICA1 RAB40A PICALM BDNF NCS1 ARF6 MYOF SLC8A3 EFNB2 SNAP91 RAB40AL EGFLAM CTNNA2 NOS1 | 1.64e-04 | 886 | 133 | 16 | GO:0098793 |
| GeneOntologyCellularComponent | extrinsic component of presynaptic membrane | 1.92e-04 | 18 | 133 | 3 | GO:0098888 | |
| GeneOntologyCellularComponent | postsynaptic density, intracellular component | 2.66e-04 | 49 | 133 | 4 | GO:0099092 | |
| GeneOntologyCellularComponent | postsynaptic specialization, intracellular component | 4.45e-04 | 56 | 133 | 4 | GO:0099091 | |
| GeneOntologyCellularComponent | somatodendritic compartment | TANC2 ARHGAP32 CALB2 RPLP0 ICA1 DAB1 SLC1A3 PICALM BDNF NCS1 ARF4 SLC8A3 EFNB2 SNAP91 ABI2 PABPC3 VPS13A NOS1 | 7.89e-04 | 1228 | 133 | 18 | GO:0036477 |
| GeneOntologyCellularComponent | extrinsic component of presynaptic endocytic zone membrane | 8.26e-04 | 7 | 133 | 2 | GO:0098894 | |
| GeneOntologyCellularComponent | dendritic spine | 9.24e-04 | 242 | 133 | 7 | GO:0043197 | |
| GeneOntologyCellularComponent | neuron spine | 1.04e-03 | 247 | 133 | 7 | GO:0044309 | |
| GeneOntologyCellularComponent | dendrite | TANC2 ARHGAP32 CALB2 RPLP0 ICA1 SLC1A3 BDNF NCS1 ARF4 SLC8A3 EFNB2 ABI2 PABPC3 NOS1 | 1.15e-03 | 858 | 133 | 14 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | TANC2 ARHGAP32 CALB2 RPLP0 ICA1 SLC1A3 BDNF NCS1 ARF4 SLC8A3 EFNB2 ABI2 PABPC3 NOS1 | 1.17e-03 | 860 | 133 | 14 | GO:0097447 |
| GeneOntologyCellularComponent | extrinsic component of synaptic membrane | 1.42e-03 | 35 | 133 | 3 | GO:0099243 | |
| GeneOntologyCellularComponent | axon terminus | 2.28e-03 | 210 | 133 | 6 | GO:0043679 | |
| MousePheno | abnormal cerebellum morphology | TRPC3 KHDRBS2 DAB1 EFCAB3 SLC1A3 PREX2 BDNF COQ8A LMX1B ROBO2 PAX5 CTNNA2 ABCD2 NIPBL | 1.22e-06 | 389 | 105 | 14 | MP:0000849 |
| MousePheno | abnormal metencephalon morphology | TRPC3 KHDRBS2 DAB1 EFCAB3 SLC1A3 PREX2 BDNF COQ8A LMX1B ROBO2 PAX5 CTNNA2 ABCD2 NIPBL | 2.99e-06 | 420 | 105 | 14 | MP:0000847 |
| MousePheno | abnormal hindbrain morphology | TRPC3 KHDRBS2 DAB1 EFCAB3 SLC1A3 PREX2 BDNF COQ8A LMX1B ROBO2 PAX5 CTNNA2 ABCD2 NIPBL | 1.54e-05 | 485 | 105 | 14 | MP:0000841 |
| MousePheno | increased susceptibility to ototoxicity-induced hearing loss | 5.59e-05 | 2 | 105 | 2 | MP:0004611 | |
| Domain | UDPGT | 3.79e-09 | 21 | 124 | 6 | PF00201 | |
| Domain | UDPGT | 3.79e-09 | 21 | 124 | 6 | PS00375 | |
| Domain | UDP_glucos_trans | 3.79e-09 | 21 | 124 | 6 | IPR002213 | |
| Domain | Small_GTPase | 1.21e-06 | 160 | 124 | 9 | IPR001806 | |
| Domain | ARF | 1.24e-06 | 29 | 124 | 5 | PS51417 | |
| Domain | Small_GTPase_ARF | 1.24e-06 | 29 | 124 | 5 | IPR024156 | |
| Domain | Small_GTP-bd_dom | 1.73e-06 | 167 | 124 | 9 | IPR005225 | |
| Domain | Arf | 1.76e-06 | 31 | 124 | 5 | PF00025 | |
| Domain | Small_GTPase_ARF/SAR | 2.43e-06 | 33 | 124 | 5 | IPR006689 | |
| Domain | P-loop_NTPase | TANC2 DDX49 DNAH10 BTAF1 RFC1 RAB40A NLRP3 ARF1 ARF3 ARF4 ABCB1 ARF5 ARF6 RABL2B RABL2A RAB40AL ABCD2 DDX41 | 1.24e-05 | 848 | 124 | 18 | IPR027417 |
| Domain | - | DDX49 DNAH10 BTAF1 RFC1 RAB40A ARF1 ARF3 ARF4 ABCB1 ARF5 ARF6 RABL2B RABL2A RAB40AL ABCD2 DDX41 | 3.48e-05 | 746 | 124 | 16 | 3.40.50.300 |
| Domain | Clathrin_AP_2 | 4.37e-05 | 2 | 124 | 2 | IPR014712 | |
| Domain | - | 4.37e-05 | 2 | 124 | 2 | 1.20.58.150 | |
| Domain | ANTH_dom | 2.60e-04 | 4 | 124 | 2 | IPR011417 | |
| Domain | ANTH | 2.60e-04 | 4 | 124 | 2 | PF07651 | |
| Domain | UbiB_dom | 4.32e-04 | 5 | 124 | 2 | IPR004147 | |
| Domain | ABC1 | 4.32e-04 | 5 | 124 | 2 | PF03109 | |
| Domain | LRR_6 | 4.86e-04 | 55 | 124 | 4 | PF13516 | |
| Domain | SURP | 6.45e-04 | 6 | 124 | 2 | PS50128 | |
| Domain | Surp | 6.45e-04 | 6 | 124 | 2 | PF01805 | |
| Domain | SWAP | 6.45e-04 | 6 | 124 | 2 | SM00648 | |
| Domain | Surp | 6.45e-04 | 6 | 124 | 2 | IPR000061 | |
| Domain | ENTH_VHS | 9.20e-04 | 29 | 124 | 3 | IPR008942 | |
| Domain | EF_Hand_1_Ca_BS | 1.11e-03 | 175 | 124 | 6 | IPR018247 | |
| Domain | RAB | 1.41e-03 | 73 | 124 | 4 | PS51419 | |
| Domain | EF-hand_8 | 1.47e-03 | 34 | 124 | 3 | PF13833 | |
| Domain | ENTH | 1.53e-03 | 9 | 124 | 2 | PS50942 | |
| Domain | NaCa_Exmemb | 1.53e-03 | 9 | 124 | 2 | IPR004837 | |
| Domain | Na_Ca_ex | 1.53e-03 | 9 | 124 | 2 | PF01699 | |
| Domain | ENTH | 1.53e-03 | 9 | 124 | 2 | SM00273 | |
| Domain | ENTH | 1.90e-03 | 10 | 124 | 2 | IPR013809 | |
| Domain | Flavoprot_Pyr_Nucl_cyt_Rdtase | 1.90e-03 | 10 | 124 | 2 | IPR001709 | |
| Domain | Chromo_dom_subgr | 1.90e-03 | 10 | 124 | 2 | IPR017984 | |
| Pathway | REACTOME_GLUCURONIDATION | 1.45e-08 | 25 | 97 | 6 | M17787 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 1.45e-08 | 25 | 97 | 6 | M605 | |
| Pathway | WP_GLUCURONIDATION | 1.87e-08 | 26 | 97 | 6 | M39404 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 3.03e-08 | 28 | 97 | 6 | M19580 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 6.09e-08 | 52 | 97 | 7 | M14171 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 3.36e-07 | 41 | 97 | 6 | M7399 | |
| Pathway | REACTOME_PREDNISONE_ADME | 4.24e-07 | 23 | 97 | 5 | MM16639 | |
| Pathway | REACTOME_ASPIRIN_ADME | 5.19e-07 | 44 | 97 | 6 | M45014 | |
| Pathway | REACTOME_GLUCURONIDATION | 5.33e-07 | 24 | 97 | 5 | MM14599 | |
| Pathway | WP_GLUCURONIDATION | 6.62e-07 | 25 | 97 | 5 | MM15820 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 1.27e-06 | 51 | 97 | 6 | M17726 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 2.01e-06 | 55 | 97 | 6 | M14933 | |
| Pathway | REACTOME_ATORVASTATIN_ADME | 2.71e-06 | 15 | 97 | 4 | MM15697 | |
| Pathway | KEGG_RETINOL_METABOLISM | 4.93e-06 | 64 | 97 | 6 | M9488 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 8.35e-06 | 70 | 97 | 6 | M16794 | |
| Pathway | REACTOME_HEME_DEGRADATION | 9.38e-06 | 20 | 97 | 4 | MM14721 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 9.84e-06 | 72 | 97 | 6 | M9257 | |
| Pathway | REACTOME_DRUG_ADME | 9.87e-06 | 109 | 97 | 7 | M45012 | |
| Pathway | REACTOME_ASPIRIN_ADME | 1.37e-05 | 45 | 97 | 5 | MM15694 | |
| Pathway | WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY | 5.75e-05 | 31 | 97 | 4 | M39476 | |
| Pathway | WP_PREGNANE_X_RECEPTOR_PATHWAY | 6.53e-05 | 32 | 97 | 4 | M39567 | |
| Pathway | REACTOME_METABOLISM_OF_PORPHYRINS | 6.53e-05 | 32 | 97 | 4 | MM14719 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 1.04e-04 | 109 | 97 | 6 | M18788 | |
| Pathway | WP_CODEINE_AND_MORPHINE_METABOLISM | 1.09e-04 | 14 | 97 | 3 | M39328 | |
| Pathway | REACTOME_DRUG_ADME | 1.69e-04 | 119 | 97 | 6 | MM15692 | |
| Pathway | WP_ESTROGEN_METABOLISM_WP697 | 2.39e-04 | 18 | 97 | 3 | M39424 | |
| Pathway | WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873 | 2.53e-04 | 45 | 97 | 4 | M39615 | |
| Pathway | WP_ESTROGEN_METABOLISM | 4.42e-04 | 22 | 97 | 3 | MM15888 | |
| Pathway | REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS | 5.49e-04 | 55 | 97 | 4 | MM15098 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 5.70e-04 | 98 | 97 | 5 | MM15352 | |
| Pathway | REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS | 5.88e-04 | 56 | 97 | 4 | M1877 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 6.25e-04 | 100 | 97 | 5 | M27650 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 6.84e-04 | 102 | 97 | 5 | M27648 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 8.50e-04 | 107 | 97 | 5 | MM14595 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 9.62e-04 | 110 | 97 | 5 | MM15350 | |
| Pathway | REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING | 1.44e-03 | 71 | 97 | 4 | MM14787 | |
| Pathway | REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING | 1.52e-03 | 72 | 97 | 4 | M539 | |
| Pathway | REACTOME_ATORVASTATIN_ADME | 1.63e-03 | 9 | 97 | 2 | M45020 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_CONTROL_BILE_ACID_HOMEOSTASIS | 1.63e-03 | 9 | 97 | 2 | M29809 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | 1.64e-03 | 183 | 97 | 6 | M39588 | |
| Pubmed | ADP-ribosylation factor is functionally and physically associated with the Golgi complex. | 8.18e-13 | 5 | 135 | 5 | 2105501 | |
| Pubmed | Genome-wide analysis of hepatic lipid content in extreme obesity. | 5.13e-12 | 13 | 135 | 6 | 25246029 | |
| Pubmed | 4.54e-11 | 8 | 135 | 5 | 8947846 | ||
| Pubmed | 4.54e-11 | 8 | 135 | 5 | 8195219 | ||
| Pubmed | 1.02e-10 | 9 | 135 | 5 | 22511988 | ||
| Pubmed | 1.02e-10 | 9 | 135 | 5 | 1339448 | ||
| Pubmed | 2.03e-10 | 10 | 135 | 5 | 23642732 | ||
| Pubmed | 2.03e-10 | 10 | 135 | 5 | 11465080 | ||
| Pubmed | 2.03e-10 | 10 | 135 | 5 | 23371916 | ||
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | 2.03e-10 | 10 | 135 | 5 | 22558097 | |
| Pubmed | 2.17e-10 | 4 | 135 | 4 | 8491770 | ||
| Pubmed | 6.34e-10 | 12 | 135 | 5 | 19419973 | ||
| Pubmed | Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. | 6.34e-10 | 12 | 135 | 5 | 11434514 | |
| Pubmed | UGT1A1 is a major locus influencing bilirubin levels in African Americans. | 1.03e-09 | 13 | 135 | 5 | 22085899 | |
| Pubmed | 1.59e-09 | 14 | 135 | 5 | 21646302 | ||
| Pubmed | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. | 1.59e-09 | 14 | 135 | 5 | 10836148 | |
| Pubmed | 1.59e-09 | 14 | 135 | 5 | 9295054 | ||
| Pubmed | Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. | 1.59e-09 | 14 | 135 | 5 | 14672974 | |
| Pubmed | Analysis of inherited genetic variations at the UGT1 locus in the French-Canadian population. | 3.24e-09 | 6 | 135 | 4 | 19204906 | |
| Pubmed | Genome-wide association meta-analysis for total serum bilirubin levels. | 3.45e-09 | 16 | 135 | 5 | 19414484 | |
| Pubmed | Genome-wide association of serum bilirubin levels in Korean population. | 4.87e-09 | 17 | 135 | 5 | 20639394 | |
| Pubmed | 7.53e-09 | 7 | 135 | 4 | 11950392 | ||
| Pubmed | A genome-wide assessment of variability in human serum metabolism. | 9.10e-09 | 19 | 135 | 5 | 23281178 | |
| Pubmed | Discovery and refinement of loci associated with lipid levels. | DNAJC13 UGT1A6 UGT1A5 CAPN3 RFC1 SNX13 UGT1A4 UGT1A1 UGT1A3 SUGP1 | 1.11e-08 | 211 | 135 | 10 | 24097068 |
| Pubmed | 1.50e-08 | 8 | 135 | 4 | 20610558 | ||
| Pubmed | 1.50e-08 | 8 | 135 | 4 | 22579593 | ||
| Pubmed | Coated vesicle assembly in the Golgi requires only coatomer and ARF proteins from the cytosol. | 1.50e-08 | 8 | 135 | 4 | 8355790 | |
| Pubmed | 1.50e-08 | 8 | 135 | 4 | 17179145 | ||
| Pubmed | 1.50e-08 | 8 | 135 | 4 | 11926829 | ||
| Pubmed | Genetic determinants influencing human serum metabolome among African Americans. | 3.28e-08 | 24 | 135 | 5 | 24625756 | |
| Pubmed | 4.48e-08 | 10 | 135 | 4 | 10828067 | ||
| Pubmed | 5.72e-08 | 3 | 135 | 3 | 1447192 | ||
| Pubmed | 5.72e-08 | 3 | 135 | 3 | 12051676 | ||
| Pubmed | 5.72e-08 | 3 | 135 | 3 | 23783033 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | TANC2 METTL3 DNAJC13 U2SURP BTAF1 AP3B1 PICALM ARF4 ARF5 NCOR2 BUB1B MED12L DDX41 NIPBL | 6.91e-08 | 582 | 135 | 14 | 20467437 |
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 1.05e-07 | 12 | 135 | 4 | 20308471 | |
| Pubmed | 1.05e-07 | 12 | 135 | 4 | 18161889 | ||
| Pubmed | 1.05e-07 | 12 | 135 | 4 | 14557543 | ||
| Pubmed | Genetic variations and haplotypes of UDP-glucuronosyltransferase 1A locus in a Korean population. | 2.28e-07 | 4 | 135 | 3 | 18223459 | |
| Pubmed | 2.28e-07 | 4 | 135 | 3 | 1898728 | ||
| Pubmed | 2.28e-07 | 4 | 135 | 3 | 15855726 | ||
| Pubmed | 2.28e-07 | 4 | 135 | 3 | 9535849 | ||
| Pubmed | 2.28e-07 | 4 | 135 | 3 | 8280139 | ||
| Pubmed | 2.28e-07 | 4 | 135 | 3 | 1634050 | ||
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 2.28e-07 | 4 | 135 | 3 | 10469592 | |
| Pubmed | 2.28e-07 | 4 | 135 | 3 | 15679100 | ||
| Pubmed | 2.28e-07 | 4 | 135 | 3 | 8276413 | ||
| Pubmed | 2.28e-07 | 4 | 135 | 3 | 10589680 | ||
| Pubmed | 2.30e-07 | 66 | 135 | 6 | 19898482 | ||
| Pubmed | 5.69e-07 | 5 | 135 | 3 | 9038142 | ||
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 5.69e-07 | 5 | 135 | 3 | 12629516 | |
| Pubmed | Layer positioning of late-born cortical interneurons is dependent on Reelin but not p35 signaling. | 5.69e-07 | 5 | 135 | 3 | 16452688 | |
| Pubmed | 5.69e-07 | 5 | 135 | 3 | 10749932 | ||
| Pubmed | 5.69e-07 | 5 | 135 | 3 | 7677729 | ||
| Pubmed | TANC2 ARHGAP32 DNAJC13 JAKMIP3 SLC1A3 PICALM ARF3 ARF5 NCOR2 SNAP91 ABI2 PABPC3 CTNNA2 NOS1 NIPBL EPB41L1 | 1.12e-06 | 963 | 135 | 16 | 28671696 | |
| Pubmed | An Arf/Rab cascade controls the growth and invasiveness of glioblastoma. | 1.13e-06 | 6 | 135 | 3 | 33443570 | |
| Pubmed | WLS retrograde transport to the endoplasmic reticulum during Wnt secretion. | 1.13e-06 | 6 | 135 | 3 | 24768165 | |
| Pubmed | 1.13e-06 | 6 | 135 | 3 | 15063128 | ||
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 1.88e-06 | 94 | 135 | 6 | 21542922 | |
| Pubmed | Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37. | 1.98e-06 | 7 | 135 | 3 | 8467709 | |
| Pubmed | 1.98e-06 | 7 | 135 | 3 | 8464825 | ||
| Pubmed | Identification of a new Pyk2 target protein with Arf-GAP activity. | 1.98e-06 | 7 | 135 | 3 | 10022920 | |
| Pubmed | Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration. | RPLP0 DCP2 SLC1A3 REEP2 ARF3 ARF4 ARF5 SNAP91 ABI2 GLG1 CTNNA2 EPB41L1 | 2.00e-06 | 558 | 135 | 12 | 35063084 |
| Pubmed | Human metabolic individuality in biomedical and pharmaceutical research. | 2.91e-06 | 57 | 135 | 5 | 21886157 | |
| Pubmed | Expression analysis of type I ARF small GTPases ARF1-3 during mouse brain development. | 3.16e-06 | 8 | 135 | 3 | 38227057 | |
| Pubmed | Involvement of human UGT2B7 and 2B15 in rofecoxib metabolism. | 3.16e-06 | 8 | 135 | 3 | 12695355 | |
| Pubmed | Layer acquisition by cortical GABAergic interneurons is independent of Reelin signaling. | 4.72e-06 | 9 | 135 | 3 | 16807322 | |
| Pubmed | 9.22e-06 | 11 | 135 | 3 | 18695635 | ||
| Pubmed | 1.23e-05 | 12 | 135 | 3 | 30631079 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 2474826 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 8068691 | ||
| Pubmed | Diffusional spread and confinement of newly exocytosed synaptic vesicle proteins. | 1.50e-05 | 2 | 135 | 2 | 26399746 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 29958886 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 27732084 | ||
| Pubmed | Human ADP-ribosylation factors. A functionally conserved family of GTP-binding proteins. | 1.50e-05 | 2 | 135 | 2 | 1899243 | |
| Pubmed | Arf family GTP loading is activated by, and generates, positive membrane curvature. | 1.50e-05 | 2 | 135 | 2 | 18597672 | |
| Pubmed | Structure of the human ADP-ribosylation factor 1 complexed with GDP. | 1.50e-05 | 2 | 135 | 2 | 7990966 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 24641623 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 22450351 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 20138207 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 24916416 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 20686835 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 26857783 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 34480602 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 27749554 | ||
| Pubmed | Turning CALM into excitement: AP180 and CALM in endocytosis and disease. | 1.50e-05 | 2 | 135 | 2 | 22639918 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 25773595 | ||
| Pubmed | Arf1 and Arf6 Synergistically Maintain Survival of T Cells during Activation. | 1.50e-05 | 2 | 135 | 2 | 33310872 | |
| Pubmed | ADP-ribosylation factors regulate the development of CT signaling in immature human enterocytes. | 1.50e-05 | 2 | 135 | 2 | 19359423 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 19406951 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 16896007 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 20504240 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 16669702 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 19349543 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 1577740 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 8661066 | ||
| Pubmed | Dysregulation of CLOCK gene expression in hyperoxia-induced lung injury. | 1.50e-05 | 2 | 135 | 2 | 24696144 | |
| Pubmed | Cerebellar Ataxia and Coenzyme Q Deficiency through Loss of Unorthodox Kinase Activity. | 1.50e-05 | 2 | 135 | 2 | 27499294 | |
| Pubmed | A Novel Sequence in AP180 and CALM Promotes Efficient Clathrin Binding and Assembly. | 1.50e-05 | 2 | 135 | 2 | 27574975 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 12480553 | ||
| Interaction | DENND1A interactions | 3.52e-06 | 101 | 127 | 7 | int:DENND1A | |
| Interaction | AP4E1 interactions | 2.27e-05 | 54 | 127 | 5 | int:AP4E1 | |
| Interaction | AP3B1 interactions | 2.48e-05 | 187 | 127 | 8 | int:AP3B1 | |
| Interaction | AP3S2 interactions | 2.74e-05 | 28 | 127 | 4 | int:AP3S2 | |
| Interaction | ARFIP2 interactions | 5.10e-05 | 104 | 127 | 6 | int:ARFIP2 | |
| Interaction | CLINT1 interactions | 5.10e-05 | 207 | 127 | 8 | int:CLINT1 | |
| Cytoband | 2q37 | 3.14e-08 | 31 | 134 | 5 | 2q37 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q37 | 5.66e-05 | 226 | 134 | 6 | chr2q37 | |
| Cytoband | 1p33-p32 | 3.00e-04 | 9 | 134 | 2 | 1p33-p32 | |
| GeneFamily | UDP glucuronosyltransferases | 7.42e-09 | 32 | 85 | 6 | 363 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 3.15e-07 | 31 | 85 | 5 | 357 | |
| GeneFamily | RAB like GTPases | 2.16e-04 | 5 | 85 | 2 | 394 | |
| GeneFamily | EF-hand domain containing | 5.82e-04 | 219 | 85 | 6 | 863 | |
| GeneFamily | C2 domain containing|Calpains | 2.20e-03 | 15 | 85 | 2 | 975 | |
| Coexpression | GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_20MIN_UP | 5.42e-06 | 195 | 128 | 8 | M6899 | |
| Coexpression | GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_RAG2_KO_NK_CELL_DN | 6.07e-06 | 198 | 128 | 8 | M8874 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.12e-06 | 184 | 129 | 7 | 15ea746c77785120f69f9ab370fb7eb9b70692f8 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-alveolar_macrophage|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.12e-06 | 184 | 129 | 7 | bd5e8fc453a6393b8778734a2c3c2f1281769bcd | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.29e-06 | 188 | 129 | 7 | c00ba0abd0c7bb2c8f9166a2ac6220aae4f4d857 | |
| ToppCell | P15-Epithelial-epithelial_progenitor_cell-epi_progenitor|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.04e-06 | 159 | 129 | 6 | a4bfd59c53237964fc24a24de5c1925fdd01db99 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.30e-06 | 160 | 129 | 6 | 97c899df1b57fd2bd1867e02bfedf1920c00ad17 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Macrophage|lymph-node_spleen / Manually curated celltypes from each tissue | 1.38e-05 | 179 | 129 | 6 | b4430f633711cecf793e8e76e766a66ff1eff473 | |
| ToppCell | IIH-Treg-proli_CD4|IIH / Condition, Cell_class and T cell subcluster | 1.52e-05 | 182 | 129 | 6 | 5c7d02da9ca2bca49db9832704b6894dfaa08a71 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-05 | 183 | 129 | 6 | ec3c05b9ce1e0fbb720e0dea41f1e28fd3fd878f | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-05 | 184 | 129 | 6 | 3261d767d5e3d9e9fbac22ad73ca14e44beed89c | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.88e-05 | 189 | 129 | 6 | 98f517af255ef234eefc3ed7e6c1d63331ab8af0 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-05 | 189 | 129 | 6 | e059be2965cca70ff5576df055d0af1775b76e00 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.88e-05 | 189 | 129 | 6 | f7e9b6e6a4de297b660a5b6c9a62f860c147185e | |
| ToppCell | (2)_NK/T-(210)_NKT_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 1.88e-05 | 189 | 129 | 6 | fa72e87e1e8cd7cbddae7b47e19cf90d181820a7 | |
| ToppCell | (2)_NK/T-(21)_NKT_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 1.88e-05 | 189 | 129 | 6 | b37ad24898a14a4a3b2d6cea2637de2471f76e20 | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 2.12e-05 | 193 | 129 | 6 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | Myeloid-Myeloid-C_(Cd16+_Monocyte)|Myeloid / shred on cell class and cell subclass (v4) | 2.32e-05 | 117 | 129 | 5 | d1936e76a935216783a73ab414e4147fa48e68eb | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-Mes-Like-AT1-AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.58e-05 | 128 | 129 | 5 | 082b3dc312b033c9b21cf73499009a1dc049ee2b | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Npy_(Cortical_subplate_interneuron)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.59e-05 | 64 | 129 | 4 | 28acc0d394b8cd2fd93ae5e0801f0ff1dd4b16ac | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Npy_(Cortical_subplate_interneuron)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.59e-05 | 64 | 129 | 4 | 61414e0fa2242f156f0f45f8733b831b7f965dd8 | |
| ToppCell | Control-Classical_Monocyte-|Classical_Monocyte / Disease condition and Cell class | 3.85e-05 | 130 | 129 | 5 | 4433b40b099845f113993b6ecf85ec594b4b9219 | |
| Drug | C1 11-32 | 4.93e-10 | 18 | 128 | 6 | CID000443077 | |
| Drug | C11131 | 4.93e-10 | 18 | 128 | 6 | CID000443076 | |
| Drug | AC1MRQNQ | 6.42e-10 | 9 | 128 | 5 | CID003522271 | |
| Drug | DHPASiU | 6.42e-10 | 9 | 128 | 5 | CID000197602 | |
| Drug | 3-iodophenol | 6.42e-10 | 9 | 128 | 5 | CID000012272 | |
| Drug | AC1L4J7U | 6.42e-10 | 9 | 128 | 5 | CID000186631 | |
| Drug | Chebi:32663 | 6.42e-10 | 9 | 128 | 5 | CID005460873 | |
| Drug | tectochrysin | 1.02e-09 | 20 | 128 | 6 | CID005281954 | |
| Drug | N-Fg | 1.35e-09 | 37 | 128 | 7 | CID000445227 | |
| Drug | estriol-16-glucuronide | 1.42e-09 | 21 | 128 | 6 | CID000122281 | |
| Drug | Fm 4-64 | 2.03e-09 | 90 | 128 | 9 | CID002733635 | |
| Drug | 4-nitrophenyl)imidazole | 2.33e-09 | 11 | 128 | 5 | CID000123155 | |
| Drug | AC1O5XMV | 2.33e-09 | 11 | 128 | 5 | CID006442661 | |
| Drug | estradiol-3-glucuronide | 2.62e-09 | 23 | 128 | 6 | CID000066651 | |
| Drug | N-OH-DABZ | 3.98e-09 | 12 | 128 | 5 | CID000051366 | |
| Drug | 1-O-beta-D-glucopyranosyl-D-mannitol | 3.98e-09 | 12 | 128 | 5 | CID000088735 | |
| Drug | 2,4,6-TCB | 3.98e-09 | 12 | 128 | 5 | CID000037247 | |
| Drug | nonanoyl-N-methylglucamide | 3.98e-09 | 12 | 128 | 5 | CID000160090 | |
| Drug | 7,7,7-triphenylheptanoic acid | 3.98e-09 | 12 | 128 | 5 | CID000276709 | |
| Drug | tritanol | 6.44e-09 | 13 | 128 | 5 | CID000006457 | |
| Drug | 5-azido-UDP-glucuronic acid | 6.44e-09 | 13 | 128 | 5 | CID003081279 | |
| Drug | cotinine-N-glucuronide | 6.44e-09 | 13 | 128 | 5 | CID000000411 | |
| Drug | erucin | 9.55e-09 | 28 | 128 | 6 | CID000078160 | |
| Drug | propranolol glucuronide | 9.98e-09 | 14 | 128 | 5 | CID000119515 | |
| Drug | PCB-61 | 9.98e-09 | 14 | 128 | 5 | CID000036401 | |
| Drug | 7-hydroxycoumarin glucuronide | 1.20e-08 | 29 | 128 | 6 | CID000125641 | |
| Drug | trans-3'-hydroxycotinine | 1.20e-08 | 29 | 128 | 6 | CID000000414 | |
| Drug | 16-epiestriol | 1.22e-08 | 77 | 128 | 8 | CID000003269 | |
| Drug | 2,2',3,5,5'-pentachlorobiphenyl | 1.49e-08 | 15 | 128 | 5 | CID000040469 | |
| Drug | afloqualone | 1.49e-08 | 15 | 128 | 5 | CID000002040 | |
| Drug | naphthyl sulphate | 1.49e-08 | 15 | 128 | 5 | CID000114775 | |
| Drug | coumarin-3-carboxylic acid | 1.49e-08 | 15 | 128 | 5 | CID000010752 | |
| Drug | sulforaphane nitrile | 1.49e-08 | 15 | 128 | 5 | CID000543743 | |
| Drug | AC1L9E0Q | 1.49e-08 | 30 | 128 | 6 | CID000443095 | |
| Drug | AC1NQGK1 | 1.63e-08 | 52 | 128 | 7 | CID005195977 | |
| Drug | quercetin-3,4'-diglucoside | 2.16e-08 | 16 | 128 | 5 | CID005320835 | |
| Drug | 1'-hydroxyestragole | 2.16e-08 | 16 | 128 | 5 | CID000040003 | |
| Drug | bilirubin-phosphate | 2.16e-08 | 16 | 128 | 5 | CID005497144 | |
| Drug | AC1Q6OQG | 2.74e-08 | 33 | 128 | 6 | CID000009686 | |
| Drug | 6-methylsalicylic acid | 2.74e-08 | 33 | 128 | 6 | CID000011279 | |
| Drug | BP-3,6-quinol | 2.74e-08 | 33 | 128 | 6 | CID000119292 | |
| Drug | geniposide | 2.74e-08 | 33 | 128 | 6 | CID000107848 | |
| Drug | 3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one | 3.04e-08 | 17 | 128 | 5 | CID000003573 | |
| Drug | 6-hydroxychrysene | 3.04e-08 | 17 | 128 | 5 | CID000037766 | |
| Drug | phenolphthalein | 3.56e-08 | 58 | 128 | 7 | CID000004764 | |
| Drug | AC1NOWCJ | 3.98e-08 | 35 | 128 | 6 | CID005120112 | |
| Drug | 3-[(3S,5R,10S,13R,14S,17R)-3-[(2S,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one | 3.98e-08 | 35 | 128 | 6 | CID010436171 | |
| Drug | estrone-3-glucuronide | 3.98e-08 | 35 | 128 | 6 | CID000115255 | |
| Drug | SN-38G | 4.03e-08 | 59 | 128 | 7 | CID000443154 | |
| Drug | SureCN12722713 | 4.19e-08 | 18 | 128 | 5 | CID005488034 | |
| Drug | ethyl-beta-D-6-glucosiduronic acid | 4.19e-08 | 18 | 128 | 5 | CID000152226 | |
| Drug | Br 2 | 4.19e-08 | 18 | 128 | 5 | CID003060900 | |
| Drug | 2,3,7-trichlorodibenzo-p-dioxin | 4.19e-08 | 18 | 128 | 5 | CID000036614 | |
| Drug | ApApG | 4.19e-08 | 18 | 128 | 5 | CID003081975 | |
| Drug | bevirimat | 4.76e-08 | 36 | 128 | 6 | CID000457928 | |
| Drug | acotiamide | 5.65e-08 | 37 | 128 | 6 | CID005282338 | |
| Drug | 6beta-hydroxytestosterone | 5.65e-08 | 37 | 128 | 6 | CID000065543 | |
| Drug | l-borneol | 5.65e-08 | 37 | 128 | 6 | CID000010049 | |
| Drug | 9-OH-risperidone | 5.67e-08 | 19 | 128 | 5 | CID000475100 | |
| Drug | 5alpha-spirostan-3beta-ol | 5.67e-08 | 19 | 128 | 5 | CID000091433 | |
| Drug | almokalant | 5.67e-08 | 19 | 128 | 5 | CID003033962 | |
| Drug | acacetin | 6.68e-08 | 38 | 128 | 6 | CID005280442 | |
| Drug | AC1L1OBF | 7.52e-08 | 20 | 128 | 5 | CID000032736 | |
| Drug | 4'-hydroxydiclofenac | 7.52e-08 | 20 | 128 | 5 | CID000116545 | |
| Drug | 1-phenylimidazole | 7.86e-08 | 39 | 128 | 6 | CID000081595 | |
| Drug | harmol | 9.21e-08 | 40 | 128 | 6 | CID000068094 | |
| Drug | dulcin | 9.83e-08 | 21 | 128 | 5 | CID000009013 | |
| Drug | Benzamidoxime hydrochloride | 9.83e-08 | 21 | 128 | 5 | CID000069186 | |
| Drug | AC1MRGT8 | 9.89e-08 | 67 | 128 | 7 | CID003517815 | |
| Drug | testosterone glucuronide | 1.07e-07 | 41 | 128 | 6 | CID000108192 | |
| Drug | L 654969 | 1.25e-07 | 42 | 128 | 6 | CID000005218 | |
| Drug | amonafide | 1.27e-07 | 22 | 128 | 5 | CID000050515 | |
| Drug | N-methylpiperazine | 1.27e-07 | 22 | 128 | 5 | CID000053167 | |
| Drug | androsterone glucuronide | 1.44e-07 | 43 | 128 | 6 | CID000114833 | |
| Drug | 7,8-benzoquinoline | 1.44e-07 | 43 | 128 | 6 | CID000009191 | |
| Drug | amidoxime | 1.61e-07 | 23 | 128 | 5 | CID000465967 | |
| Drug | phenanthridine | 1.61e-07 | 23 | 128 | 5 | CID000009189 | |
| Drug | MS-222 | 1.66e-07 | 44 | 128 | 6 | CID000011400 | |
| Drug | eugenol | 1.80e-07 | 73 | 128 | 7 | CID000003314 | |
| Drug | AS-3201 | 2.03e-07 | 24 | 128 | 5 | CID000153948 | |
| Drug | 5-MOP | 2.52e-07 | 25 | 128 | 5 | CID000002355 | |
| Drug | AzMC | 2.52e-07 | 25 | 128 | 5 | CID000064986 | |
| Drug | N-acetylbenzidine | 2.52e-07 | 25 | 128 | 5 | CID000018787 | |
| Drug | 5,6-benzoquinoline | 2.52e-07 | 25 | 128 | 5 | CID000006796 | |
| Drug | N-phenylmaleimide | 2.52e-07 | 25 | 128 | 5 | CID000013662 | |
| Drug | salicylamide | 2.84e-07 | 48 | 128 | 6 | CID000005147 | |
| Drug | retigabine | 2.84e-07 | 48 | 128 | 6 | CID000121892 | |
| Drug | AC1N8H7N | 2.85e-07 | 78 | 128 | 7 | CID004318740 | |
| Drug | campestrol | 3.22e-07 | 49 | 128 | 6 | CID000010134 | |
| Drug | scopoletin | 3.64e-07 | 50 | 128 | 6 | CID005280460 | |
| Drug | diflunisal | 3.80e-07 | 27 | 128 | 5 | CID000003059 | |
| Drug | DiMeIQx | 3.80e-07 | 27 | 128 | 5 | CID000104739 | |
| Drug | (+/-)-Abacavir | 4.11e-07 | 51 | 128 | 6 | CID000001971 | |
| Drug | CARMINE | 4.60e-07 | 28 | 128 | 5 | CID000014749 | |
| Drug | N-hydroxy-4-aminobiphenyl | 4.60e-07 | 28 | 128 | 5 | CID000081261 | |
| Drug | H-Ni | 4.60e-07 | 28 | 128 | 5 | CID000445665 | |
| Drug | estrone-d4 | 4.71e-07 | 168 | 128 | 9 | CID000000698 | |
| Drug | ASA404 | 5.19e-07 | 53 | 128 | 6 | CID000123964 | |
| Drug | AC1L1JAL | 5.53e-07 | 29 | 128 | 5 | CID000004954 | |
| Drug | 7-hydroxy-4-trifluoromethylcoumarin | 5.53e-07 | 29 | 128 | 5 | CID005375667 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 7.05e-11 | 17 | 128 | 6 | EFO_0004611, EFO_0007800 | |
| Disease | X-11442 measurement | 1.76e-10 | 9 | 128 | 5 | EFO_0021236 | |
| Disease | X-11441 measurement | 1.76e-10 | 9 | 128 | 5 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 1.76e-10 | 9 | 128 | 5 | EFO_0004739 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 1.76e-10 | 9 | 128 | 5 | EFO_0004570, GO_0009410 | |
| Disease | bilirubin measurement, response to tenofovir | 3.52e-10 | 10 | 128 | 5 | EFO_0004570, EFO_0009279 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 3.52e-10 | 10 | 128 | 5 | EFO_0802185 | |
| Disease | histidine betaine (hercynine) measurement | 6.42e-10 | 11 | 128 | 5 | EFO_0800972 | |
| Disease | X-21796 measurement | 6.42e-10 | 11 | 128 | 5 | EFO_0800825 | |
| Disease | insomnia, bilirubin measurement | 6.42e-10 | 11 | 128 | 5 | EFO_0004570, EFO_0004698 | |
| Disease | aldosterone measurement | 6.42e-10 | 11 | 128 | 5 | EFO_0010219 | |
| Disease | biliverdin measurement | 1.10e-09 | 12 | 128 | 5 | EFO_0021033 | |
| Disease | response to dolutegravir | 3.23e-09 | 30 | 128 | 6 | EFO_0600017 | |
| Disease | X-11793--oxidized bilirubin measurement | 2.33e-08 | 8 | 128 | 4 | EFO_0021260 | |
| Disease | Succinimide measurement | 2.33e-08 | 8 | 128 | 4 | EFO_0022118 | |
| Disease | X-11530 measurement | 2.33e-08 | 8 | 128 | 4 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 2.33e-08 | 8 | 128 | 4 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 2.33e-08 | 8 | 128 | 4 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 2.33e-08 | 8 | 128 | 4 | EFO_0800696 | |
| Disease | X-10458 measurement | 2.33e-08 | 8 | 128 | 4 | EFO_0800692 | |
| Disease | X-24849 measurement | 2.33e-08 | 8 | 128 | 4 | EFO_0800909 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 2.33e-08 | 8 | 128 | 4 | EFO_0802740 | |
| Disease | X-16946 measurement | 2.33e-08 | 8 | 128 | 4 | EFO_0800766 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 4.19e-08 | 9 | 128 | 4 | EFO_0801037 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 4.19e-08 | 9 | 128 | 4 | EFO_0801036 | |
| Disease | X-11880 measurement | 4.19e-08 | 9 | 128 | 4 | EFO_0800698 | |
| Disease | protein-tyrosine kinase 6 measurement | 4.19e-08 | 9 | 128 | 4 | EFO_0020691 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 4.19e-08 | 9 | 128 | 4 | EFO_0802127 | |
| Disease | X-21448 measurement | 6.95e-08 | 10 | 128 | 4 | EFO_0800816 | |
| Disease | X-23974 measurement | 6.95e-08 | 10 | 128 | 4 | EFO_0800867 | |
| Disease | xanthurenate measurement | 1.55e-07 | 29 | 128 | 5 | EFO_0010551 | |
| Disease | p-cresol glucuronide measurement | 1.63e-07 | 12 | 128 | 4 | EFO_0800079 | |
| Disease | retinol dehydrogenase 16 measurement | 2.34e-07 | 13 | 128 | 4 | EFO_0802007 | |
| Disease | gallstones | 4.75e-07 | 108 | 128 | 7 | EFO_0004210 | |
| Disease | angiopoietin-related protein 1 measurement | 9.86e-07 | 18 | 128 | 4 | EFO_0801382 | |
| Disease | thyroxine measurement | 1.70e-06 | 83 | 128 | 6 | EFO_0005130 | |
| Disease | tissue factor measurement | 1.91e-06 | 21 | 128 | 4 | EFO_0010623 | |
| Disease | cholelithiasis | 2.40e-06 | 88 | 128 | 6 | EFO_0004799 | |
| Disease | urate measurement, spine bone mineral density | 5.41e-06 | 58 | 128 | 5 | EFO_0004531, EFO_0007701 | |
| Disease | pregnenetriol sulfate measurement | 1.28e-05 | 11 | 128 | 3 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 1.28e-05 | 11 | 128 | 3 | EFO_0600039 | |
| Disease | Behavior Disorders | 1.70e-05 | 12 | 128 | 3 | C0004930 | |
| Disease | Mental disorders | 1.70e-05 | 12 | 128 | 3 | C0004936 | |
| Disease | Mental Disorders, Severe | 1.70e-05 | 12 | 128 | 3 | C4046029 | |
| Disease | Diagnosis, Psychiatric | 1.70e-05 | 12 | 128 | 3 | C0376338 | |
| Disease | Down syndrome (biomarker_via_orthology) | 1.87e-05 | 2 | 128 | 2 | DOID:14250 (biomarker_via_orthology) | |
| Disease | nephrotic syndrome type 9 (implicated_via_orthology) | 1.87e-05 | 2 | 128 | 2 | DOID:0080391 (implicated_via_orthology) | |
| Disease | primary coenzyme Q10 deficiency 4 (implicated_via_orthology) | 1.87e-05 | 2 | 128 | 2 | DOID:0070241 (implicated_via_orthology) | |
| Disease | pregnenetriol disulfate measurement | 2.21e-05 | 13 | 128 | 3 | EFO_0800587 | |
| Disease | Schizophrenia | ARHGAP32 CLOCK SLC1A3 ADCY7 BDNF NCS1 FABP5 ABCB1 UGT1A3 EFNB2 LMX1B ERVK-8 CTNNA2 NOS1 | 3.09e-05 | 883 | 128 | 14 | C0036341 |
| Disease | X-21441 measurement | 5.19e-05 | 17 | 128 | 3 | EFO_0800814 | |
| Disease | hereditary spastic paraplegia 76 (implicated_via_orthology) | 1.85e-04 | 5 | 128 | 2 | DOID:0110821 (implicated_via_orthology) | |
| Disease | non-high density lipoprotein cholesterol measurement | DNAJC13 DNAH10 UGT1A6 UGT1A5 CARMIL1 DAB1 UGT1A4 UGT1A1 UGT1A3 FAM50A SUGP1 | 2.86e-04 | 713 | 128 | 11 | EFO_0005689 |
| Disease | coenzyme Q10 deficiency disease (implicated_via_orthology) | 3.87e-04 | 7 | 128 | 2 | DOID:0050730 (implicated_via_orthology) | |
| Disease | hormone measurement | 4.98e-04 | 84 | 128 | 4 | EFO_0004730 | |
| Disease | serum N-desmethylclozapine measurement | 5.14e-04 | 8 | 128 | 2 | EFO_0600043 | |
| Disease | plasma clozapine measurement | 5.14e-04 | 8 | 128 | 2 | EFO_0600038 | |
| Disease | Parkinson Disease | 5.21e-04 | 85 | 128 | 4 | C0030567 | |
| Disease | vitamin D deficiency | 5.56e-04 | 37 | 128 | 3 | EFO_0003762 | |
| Disease | Liver Cirrhosis, Experimental | ANXA4 U2SURP ABCB1 NCOR2 CROT SLC20A1 PKLR DIO1 ROBO2 EPCAM FAM43A | 5.69e-04 | 774 | 128 | 11 | C0023893 |
| Disease | aspartate aminotransferase measurement | PIK3AP1 DNAJC13 CARMIL1 KHDRBS2 BDNF NLRP3 SNX13 ABCB1 NCOR2 CROT SUGP1 CTNNA2 | 5.84e-04 | 904 | 128 | 12 | EFO_0004736 |
| Disease | apolipoprotein B measurement | DNAJC13 DNAH10 UGT1A6 UGT1A5 ABCB1 UGT1A4 BSND UGT1A3 MYOF SUGP1 | 6.47e-04 | 663 | 128 | 10 | EFO_0004615 |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 6.89e-04 | 243 | 128 | 6 | EFO_0004612, EFO_0020944 | |
| Disease | bilirubin measurement | 7.11e-04 | 442 | 128 | 8 | EFO_0004570 | |
| Disease | metabolite measurement | SLC24A5 UGT1A6 UGT1A5 CAPN11 UGT1A4 UGT1A1 UGT1A3 MYOF UGT2B11 | 7.75e-04 | 560 | 128 | 9 | EFO_0004725 |
| Disease | cytokine measurement | 9.33e-04 | 461 | 128 | 8 | EFO_0004873 | |
| Disease | fibrinogen measurement, tissue plasminogen activator measurement | 9.90e-04 | 45 | 128 | 3 | EFO_0004623, EFO_0004791 | |
| Disease | fibrinogen measurement, plasminogen activator inhibitor 1 measurement | 9.90e-04 | 45 | 128 | 3 | EFO_0004623, EFO_0004792 | |
| Disease | Alzheimer disease | 1.29e-03 | 485 | 128 | 8 | MONDO_0004975 | |
| Disease | Epilepsy | 1.32e-03 | 109 | 128 | 4 | C0014544 | |
| Disease | nervous system disorder | 1.59e-03 | 53 | 128 | 3 | C0027765 | |
| Disease | Ischemic stroke, fibrinogen measurement | 1.77e-03 | 55 | 128 | 3 | EFO_0004623, HP_0002140 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 1.84e-03 | 200 | 128 | 5 | EFO_0004611, EFO_0020945 | |
| Disease | factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement | 1.87e-03 | 56 | 128 | 3 | EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791 | |
| Disease | hepatic encephalopathy (biomarker_via_orthology) | 1.89e-03 | 15 | 128 | 2 | DOID:13413 (biomarker_via_orthology) | |
| Disease | fibrinogen measurement, factor VII measurement | 2.07e-03 | 58 | 128 | 3 | EFO_0004619, EFO_0004623 | |
| Disease | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | 2.09e-03 | 206 | 128 | 5 | EFO_0004612, EFO_0020947 | |
| Disease | Spermatogenic Failure, Nonobstructive, Y-Linked | 2.15e-03 | 16 | 128 | 2 | C1839071 | |
| Disease | Spermatogenic failure, Y-linked, 2 | 2.15e-03 | 16 | 128 | 2 | cv:C1839071 | |
| Disease | SPERMATOGENIC FAILURE, Y-LINKED, 2 | 2.15e-03 | 16 | 128 | 2 | 415000 | |
| Disease | Seizures | 2.67e-03 | 218 | 128 | 5 | C0036572 | |
| Disease | cystathionine measurement | 3.04e-03 | 19 | 128 | 2 | EFO_0010474 | |
| Disease | cerebral microbleeds | 3.04e-03 | 19 | 128 | 2 | EFO_0010059 | |
| Disease | Grand Mal Status Epilepticus | 3.12e-03 | 67 | 128 | 3 | C0311335 | |
| Disease | Status Epilepticus, Subclinical | 3.12e-03 | 67 | 128 | 3 | C0751522 | |
| Disease | Simple Partial Status Epilepticus | 3.12e-03 | 67 | 128 | 3 | C0751524 | |
| Disease | Non-Convulsive Status Epilepticus | 3.12e-03 | 67 | 128 | 3 | C0751523 | |
| Disease | Petit mal status | 3.12e-03 | 67 | 128 | 3 | C0270823 | |
| Disease | Complex Partial Status Epilepticus | 3.12e-03 | 67 | 128 | 3 | C0393734 | |
| Disease | Status Epilepticus | 3.25e-03 | 68 | 128 | 3 | C0038220 | |
| Disease | Osteoarthritis of hip | 3.37e-03 | 20 | 128 | 2 | C0029410 | |
| Disease | ulcerative colitis, Crohn's disease | 3.37e-03 | 20 | 128 | 2 | EFO_0000384, EFO_0000729 | |
| Disease | end stage renal disease (implicated_via_orthology) | 3.37e-03 | 20 | 128 | 2 | DOID:783 (implicated_via_orthology) | |
| Disease | Intellectual Disability | 3.44e-03 | 447 | 128 | 7 | C3714756 | |
| Disease | vitamin D measurement | 3.54e-03 | 336 | 128 | 6 | EFO_0004631 | |
| Disease | Neutropenia | 3.71e-03 | 21 | 128 | 2 | C0027947 | |
| Disease | triglyceride measurement, phospholipid measurement | 3.82e-03 | 146 | 128 | 4 | EFO_0004530, EFO_0004639 | |
| Disease | X-24947 measurement | 4.07e-03 | 22 | 128 | 2 | EFO_0800910 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GDQMDNAKRMETKGA | 396 | P35503 | |
| MAAVKKEGGALSEAM | 1 | O60566 | |
| CLVMKAEMNGSKLGR | 66 | P16422 | |
| MGKASANEMLIAGRK | 436 | Q9Y6F8 | |
| MMGKASANEMLIAGR | 436 | Q9Y6F7 | |
| KGKNGVAIMSRLFDM | 331 | Q63HQ2 | |
| AMMTMAVLSKRKGGN | 671 | O71037 | |
| AMMTMAVLSKRKGGN | 671 | Q902F8 | |
| MMTMAVLSKRKGGNV | 671 | Q9UKH3 | |
| MKAAPMKEANIRGQG | 16 | P23560 | |
| KDVLSGGEKQRMGMA | 606 | Q9UBJ2 | |
| KQMRILMVGLDAAGK | 16 | P84085 | |
| NKAIMESLSKGGNIM | 386 | Q8N6S4 | |
| ANREKMKGELGMMLS | 71 | Q9NVT9 | |
| GKATKMSRRMEAQAL | 386 | Q9BTE6 | |
| KEMRILMVGLDAAGK | 16 | P61204 | |
| ARVKKGADGVMRTMA | 146 | O60641 | |
| EMSDLLKGKNQSMRG | 306 | Q8IU60 | |
| KGDAALKMRASVRMT | 471 | P51828 | |
| AMEDAQTLRKAMKGL | 16 | P09525 | |
| RCMINLMDKDGSGKL | 616 | Q9UMQ6 | |
| KDSMIRKFLEGNSMG | 481 | Q6ZUJ8 | |
| MRKRAGASAGVLMIQ | 221 | A6NI87 | |
| GGKSREVMRLNKEDM | 71 | Q9ULK2 | |
| MLNGAGLDKALKMSL | 1 | Q9NTI2 | |
| LLRFKVSTQNMKMGG | 156 | Q9NYB9 | |
| DAMKRIVGMIAKGKN | 61 | O00203 | |
| SMAKGLNARMMRGLS | 226 | Q8WXH6 | |
| SMAKGLNARMMRGLS | 226 | P0C0E4 | |
| MTSALGKNDMKAIGL | 676 | Q96PH1 | |
| GKNDMKAIGLQMALD | 681 | Q96PH1 | |
| AMASLAGGLDDMKAN | 266 | Q02548 | |
| AGVVEMKMLSGQALK | 871 | P08183 | |
| AVGKSKLMERFLMDG | 31 | Q9UBK7 | |
| AVGKSKLMERFLMDG | 31 | Q9UNT1 | |
| NMGLEAIIRKALMGK | 2336 | Q9Y618 | |
| MENSLKSGKGAAAMI | 756 | Q9H4G0 | |
| MMKRAAAAAVGGALA | 1 | Q9H2X8 | |
| KAIMMLGDAKIGNNS | 1181 | Q86YW9 | |
| RIFAMMDKNADGKLT | 151 | P62166 | |
| SIGPMGAQRMADALK | 761 | Q7RTR2 | |
| GKGFEMKLDAMSLLA | 556 | Q86VF7 | |
| KMKGQMLGSRSLEDD | 1071 | Q86VF7 | |
| KKVARMGFNASSMLR | 16 | Q3SXM0 | |
| RAMKILMKVGQDASS | 156 | P52799 | |
| DMMKEGLSLLCKTGN | 51 | Q53EV4 | |
| HMLKEGKGRMLQAIS | 301 | P49585 | |
| MDRAALRAAAMGEKK | 1 | Q8IVT5 | |
| LGSESAKIKAMGIMD | 1241 | Q6KC79 | |
| MSKRGMSSRAKGDKA | 1 | Q5VZ66 | |
| LAQKMMIGRCNLAGK | 351 | P30613 | |
| RGEAAAGAAGMKRAM | 451 | Q6P597 | |
| AGAAGMKRAMSLNTL | 456 | Q6P597 | |
| AEGRALMSVKEMAKG | 121 | Q9UJV9 | |
| RMNSAGMKSKESGEN | 231 | Q13316 | |
| SLRGKAVVLMGKNTM | 46 | P05388 | |
| GKNTMMRKAIRGHLE | 56 | P05388 | |
| EMKAMALKGGRAEGT | 686 | A7KAX9 | |
| QAQMRKAMAKGLRGE | 501 | P52790 | |
| AMMTMAVLSKRKGGN | 1431 | P63135 | |
| LGVGIALRKMGAMAK | 26 | Q01469 | |
| SKLSAMMGAVAEKKG | 151 | Q86U44 | |
| AERAIKKMNGMLLNG | 151 | Q9H361 | |
| EAVKFSAKLMGQAMA | 741 | P29475 | |
| KGQMGSCRVGKRIME | 481 | Q9NQV7 | |
| KMLMSSVKDNVGRGL | 91 | P98173 | |
| RVKRNILAMGEKTGM | 36 | P49895 | |
| LGGRLQAKMASMKMF | 651 | O14976 | |
| MKVVRGEKGNLGMNC | 466 | Q92896 | |
| KAMGLLENGLAAEMK | 76 | Q8WZ55 | |
| MAAARGALKKNATML | 206 | P26232 | |
| RGDKLCQDSMMKLKG | 56 | O75553 | |
| CQDSMMKLKGVVAGA | 61 | O75553 | |
| KKLGLNMGEAIGMST | 151 | O14981 | |
| MMTMAVLSKRKGGNV | 561 | P61566 | |
| AMMTMAVLSKRKGGN | 671 | Q69384 | |
| MMTMAVLSKRKGGNV | 561 | P61567 | |
| MKKANDALGRELAGM | 181 | H7BZ55 | |
| LDSKASGKMGMRAVV | 111 | P43003 | |
| GAASEAGRAMHLMKK | 6 | Q14320 | |
| AVSAKREALGAVGMM | 541 | Q14055 | |
| LARMKGGREVAMKIQ | 346 | Q8NI60 | |
| KEMRILMVGLDAAGK | 16 | P84077 | |
| MEKFKAAMLLGSVGD | 1 | Q8NDY3 | |
| GLGLGVLAEMAKKSM | 101 | Q96D53 | |
| VLAEMAKKSMPGGRL | 106 | Q96D53 | |
| TIGPLMNGMKKRADT | 2091 | O75165 | |
| MNGMKKRADTVGLAC | 2096 | O75165 | |
| GTKMKLTVSAQGIRM | 106 | Q8N2R8 | |
| GAKMSILGKGSMRDK | 96 | Q5VWX1 | |
| QELEKARKGSGMMSK | 46 | P22676 | |
| GGMDMVAQALELSRK | 106 | Q9Y6V7 | |
| QVMGSGLLAEMKAKQ | 1161 | Q5VZK9 | |
| AMMTMVVLSKRKGGN | 671 | Q902F9 | |
| GMGDRKRTNSMSKEA | 21 | B1AMM8 | |
| IMKKAIERGSLMGCS | 251 | P20807 | |
| EMEAVSKAGLGMLKF | 3226 | Q8IVF4 | |
| SKAGLGMLKFVEAVM | 3231 | Q8IVF4 | |
| GLMCTVAKLGMNLTK | 71 | Q8N7B9 | |
| LRLGQMDTKGLMKAV | 331 | O43304 | |
| DMSVKAEMGLGDRKG | 481 | Q8WUM9 | |
| NKMMKDCSAGKGFDR | 491 | Q9UKG9 | |
| TKAMTEMNGRILGSK | 346 | P0CB38 | |
| QLMGDPASGKRKDME | 76 | A6NGG8 | |
| RVAAKRLKEGDTMMG | 51 | Q14914 | |
| MDGAAAAKQVMALKD | 216 | Q5BJF6 | |
| KTRAGKMMQATGKAL | 106 | Q05084 | |
| GAAGIGKTILARKMM | 226 | Q96P20 | |
| VRNGADVNAKDMLKM | 91 | Q8TAK5 | |
| KMSDNMGKMSERLGQ | 731 | Q9Y5W8 | |
| GKNTMMRKAIRGHLE | 56 | Q8NHW5 | |
| ASQDGMRRLMSKRGK | 441 | Q8N3X1 | |
| AAGGDMKKHLMLLSR | 896 | P35251 | |
| VAKMSFRAAAALMKG | 211 | Q96CC6 | |
| KMKLISNGGDSAVEM | 401 | Q86V20 | |
| MFRNSLKMLLTGGKS | 1 | Q9HCD6 | |
| LNFLARLMGGMEIKK | 296 | Q8WVF1 | |
| GRMQEKTALMKGEDG | 3226 | Q9NRC6 | |
| AERALKNLNGKMIMS | 331 | O15042 | |
| LISMKGMGDPKNRNV | 406 | O75969 | |
| KQMRILMVGLDAAGK | 16 | P18085 | |
| SKIFGNKEMRILMLG | 6 | P62330 | |
| ELGSMLPGNARKMDK | 56 | O15516 | |
| GTEMKKVARQLGMAA | 21 | Q9C0C6 | |
| MSLKMDNRDVAGKAN | 1 | Q8IWZ8 | |
| TKVKRGADGVMRTMN | 146 | Q13492 | |
| NRGKGGAVSKLMESM | 2101 | O15417 | |
| ASKITGAMAKGVAAM | 2921 | Q96RL7 | |
| ETMMRVGKRGLNLAA | 116 | Q9BRK0 | |
| KQRTGKIMGIEMASS | 246 | Q92670 | |
| NGSSDRGMKSLVNKM | 476 | Q9NUY8 | |
| DQMDNAKRMETKGAG | 396 | P22309 | |
| GDQMDNAKRMETKGA | 396 | P35504 | |
| ASVLVARKGKGDMAM | 386 | Q71RS6 | |
| ARKGKGDMAMSNIVG | 391 | Q71RS6 | |
| IKLVEKGSNAEMAGM | 616 | Q70Z35 | |
| GKLMISNTRKSDAGM | 186 | Q9HCK4 | |
| MKAKGAAVRLDFNTM | 406 | O75310 | |
| KLEGKMMNGLRNLGI | 401 | Q9NYU1 | |
| QMDNAKRMETKGAGV | 396 | P19224 | |
| AALAAMNGRKIMGKE | 61 | P31483 | |
| RLQKDIEMGMGNSKS | 721 | Q13507 | |
| GDQMDNAKRMETKGA | 396 | P22310 | |
| RGQTDCAKMLDGIKM | 16 | O60663 | |
| MMTGAGNILKKHAAE | 361 | P57103 | |
| KDGARVMAGKVEMTL | 1956 | Q9NZM1 |